Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes.
Times cited: 10
Community-based phase IIIB trial of three UPFRONT bortezomib-based myeloma regimens.
Journal of Clinical Oncology.
Times cited: 36
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
New England Journal of Medicine.
Times cited: 681